Loring Wolcott & Coolidge Fiduciary Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89M | Sell |
|
|||||
|
2025
Q1 | $2.95M | Sell |
|
|||||
|
2024
Q4 | $3.7M | Sell |
|
|||||
|
2024
Q3 | $4.16M | Sell |
|
|||||
|
2024
Q2 | $9.29M | Sell |
|
|||||
|
2024
Q1 | $11.6M | Sell |
|
|||||
|
2023
Q4 | $14.6M | Sell |
|
|||||
|
2023
Q3 | $30.5M | Sell |
|
|||||
|
2023
Q2 | $83.5M | Sell |
|
|||||
|
2023
Q1 | $77.7M | Sell |
|
|||||
|
2022
Q4 | $72.4M | Sell |
|
|||||
|
2022
Q3 | $81M | Buy |
|
|||||
|
2022
Q2 | $91.9M | Buy |
|
|||||
|
2022
Q1 | $114M | Buy |
|
|||||
|
2021
Q4 | $125M | Sell |
|
|||||
|
2021
Q3 | $111M | Buy |
|
|||||
|
2021
Q2 | $101M | Sell |
|
|||||
|
2021
Q1 | $81.9M | Buy |
|
|||||
|
2020
Q4 | $88.3M | Buy |
|
|||||
|
2020
Q3 | $65.6M | Buy |
|
|||||
|
2020
Q2 | $34.9M | Buy |
|
|||||
|
2020
Q1 | $17.8M | Buy |
|
|||||
|
2019
Q4 | $21.2M | Buy |
|
|||||
|
2019
Q3 | $19.5M | Buy |
|
|||||
|
2019
Q2 | $15.3M | Buy |
|
|||||
|
2019
Q1 | $14.6M | Buy |
|
|||||
|
2018
Q4 | $11.5M | Buy |
|
|||||
|
2018
Q3 | $12.6M | Sell |
|
|||||
|
2018
Q2 | $10.7M | Buy |
|
|||||
|
2018
Q1 | $10.2M | Buy |
|
|||||
|
2017
Q4 | $1.54M | Buy |
|
|||||
|
2017
Q3 | $888K | Buy |
|
|||||
|
2017
Q2 | $320K | Buy |
|
|||||
|
2017
Q1 | $254K | Buy |
|
|||||
|
2016
Q4 | $37K | Sell |
|
|||||
|
2016
Q3 | $84K | Hold |
|
|||||
|
2016
Q2 | $70K | Buy |
|
|||||
|
2016
Q1 | $26K | Hold |
|
|||||
|
2015
Q4 | $24K | Hold |
|
|||||
|
2015
Q3 | $21K | Hold |
|
|||||
|
2015
Q2 | $21K | Hold |
|
|||||
|
2015
Q1 | $21K | Hold |
|
|||||
|
2014
Q4 | $19K | Hold |
|
|||||
|
2014
Q3 | $15K | Hold |
|
|||||
|
2014
Q2 | $13K | Hold |
|
|||||
|
2014
Q1 | $11K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $36K | Sell |
|
|||||
|
2013
Q2 | $48K | Buy |
|